Roquette Pharma Denmark ApS
CVR 45239128 · Private limited company (ApS) · Active · High risk
Roquette Pharma Denmark ApS is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry fremstilling af farmaceutiske råvarer. Our model estimates a bankruptcy risk of 4.5% over the next 12 months, which is 3.2 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 180k and a net result of DKK 140k. CEO: Delphine DESRUMAUX.
Bankruptcy risk for Roquette Pharma Denmark ApS
3.2 × the average (1.41%) · higher risk than 91% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45239128
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- c/o Gorrissen Federspiel, Axeltorv 2
1609 København V - Municipality
- København
- Industry
- Fremstilling af farmaceutiske råvarer (211000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 13.0% |
| Current ratio | 115% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 308 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK 4.6m |
| Net profit | DKK 140k |
| Equity | DKK 180k |
| Total assets | DKK 1.4m |
| Cash | DKK 923k |
| Short-term debt | DKK 1.2m |
| Tax owed | DKK 39k |
| Avg. employees | 3 |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Crowe.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 28 Nov 2024 – 31 Dec 2025 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Delphine DESRUMAUX | Current | |
| Owner (100%) | ROQUETTE HEALTH & PHARMA SOLUTIONS | Current | |
| Auditor | KPMG P/S | Current | |
| Founder | ROQUETTE HEALTH & PHARMA SOLUTIONS | Current |
Address history (0 moves)
| c/o Gorrissen Federspiel, Axeltorv 2, 1609 København V |
Former names
| Roquette Pharma Denmark ApS | – now |
| ROQUETTE PHARMA ApS | – |
Other companies at the same address
- FOOD & FUEL ApS Bankrupt
- KHAO THAI ApS Bankrupt
- Kassandra ApS Bankrupt
- LA GIROLLE ApS Bankrupt
- M.G.5. OF COPENHAGEN ApS Bankrupt
- N25 Phoenix ApS Bankrupt
- PKHAL ApS Bankrupt
- RESTAURANT GRAABRØDRE SCALA ApS Bankrupt
- SCALA BIOGRAFER A/S Bankrupt
- SCALA INTERNATIONAL ENTERTAINMENT ApS Bankrupt
- SHOES TIME ApS Bankrupt
- SMILEY KLINIKKEN ApS Bankrupt
- VICH 3405 ApS Bankrupt
- X3M ENTERTAINMENT SCALA CITY ApS Bankrupt
- ZaaRex ApS Bankrupt
- AET Infrastructure ApS Active
- AG SNUS AKTIESELSKAB Opløst
- Aaom Holding ApS Active
- Aesthetic Medical Supplies ApS Active
- Aktieselskabet af 29. december 2021 Opløst
- Ankle ApS Active
- Anpartsselskabet af 21.08.2026 Opløst
- As1 Sports DK BidCo ApS Active
- Avenir Invest ApS Active
- Aventa ApS Compulsorily dissolved
Similar companies in København
- XELLIA PHARMACEUTICALS ApS København S
- Nature's BioCeuticals Denmark ApS København Ø
- Hyaworth ApS København Ø
- MONOZYME ApS Hellerup
- aiwell Nordic ApS København N
- Atlas Growers Denmark A/S København K
- Orenda ApS København S
- Vectocan IVS København K
- TAK Biopharma IVS København N
Questions and answers about Roquette Pharma Denmark ApS
Has Roquette Pharma Denmark ApS gone bankrupt?
No, Roquette Pharma Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Roquette Pharma Denmark ApS?
Our model estimates a bankruptcy risk of 4.5% over the next 12 months (high risk), which is 3.2 times the average for Danish companies.
Who is the CEO of Roquette Pharma Denmark ApS?
Delphine DESRUMAUX is the CEO of Roquette Pharma Denmark ApS.
Who is the auditor of Roquette Pharma Denmark ApS?
Roquette Pharma Denmark ApS most recently used KPMG P/S.
When was Roquette Pharma Denmark ApS founded?
Roquette Pharma Denmark ApS was founded on 28 November 2024.
What is the equity of Roquette Pharma Denmark ApS?
Equity was DKK 180k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.